Cantel Medical To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2017

LITTLE FALLS, N.J., March 2, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its second quarter ended January 31, 2017 on Thursday, March 9 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.

To participate in the conference call, dial 877-407-8033 (US & Canada) or 201-689-8033 (International) approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, March 9, 2017 through midnight on May 9, 2017 by dialing 877-481-4010 (US & Canada) or 919-882-2331 (International) and using conference ID #:10259

An audio webcast will be available via the Cantel website at www.cantelmedical.com.  A replay of the presentation will be archived on the Cantel web site for those unable to listen live.

About Cantel Medical 
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. 

For further information, visit the Cantel website at www.cantelmedical.com.

 

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-corp-to-hold-conference-call-to-discuss-results-for-its-second-quarter-ended-january-31-2017-300416618.html

SOURCE Cantel Medical Corp.

Back to news